Delivery Order SPE2DB22D2009-SPE2DB25FM0RH
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,271.65 by the Defense Logistics Agency on July 22, 2025, for the supply of ProQuad vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $6,405.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials with an ultimate completion date of August 12, 2025. This non-set-aside contract was competitively awarded and reflects the agency's ongoing pharmaceutical procurement through its Medical Supply Chain. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary distribution...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of ProQuad vials valued at $13,234.64 with a completion date of August 11, 2025. This non-competitive delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $3,374.88 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order will be fulfilled at AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of ProQuad vials, a combination vaccine product. This firm fixed price delivery order, valued at $6,405.01, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is non-set-aside and was competitively awarded, with performance to be completed by August 20, 2025, at AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $8,437.40 under a firm fixed price contract. This delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the contractor's corporate...
- AmerisourceBergen Drug Corp was awarded a $6,683.60 delivery order by the Defense Logistics Agency (DLA) for PROQUAD vials, with performance in Conshohocken, Pennsylvania. The contract is not set-aside, was competitively awarded at firm fixed price, and carries an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a $5,480.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $6,115.28 under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 25, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order operates as a child...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0RHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8.4K to AmerisourceBergen Drug Corp for ProQuad vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a single medical supply transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio supporting federal healthcare procurement. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems through its extensive federal contract awards. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The Defense Logistics Agency is currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, which may expand the competitive landscape for such medical supply agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 8/4/25 |